Conray 325

   
Google
 
Web NewDrugInformation.com

Conray 325


Drug - Conray 325
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Iothalamate Sodium
Multiple ingredients are in alphabetical order.

Strength - 54.3%
The potency of the active ingredient(s), Iothalamate Sodium. May repeat for multiple part products.

Applicant - MALLINCKRODT
The firm name holding legal responsibility for Conray 325. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 017685
The FDA assigned number to Conray 325. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Conray 325. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Conray 325 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Conray 325. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Conray 325 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mallinckrodt Medical Inc
The full name of the firm holding legal responsibility for the new application of Conray 325.

Conray 325